Hoffmann Lab @GladstoneInst | @UCSF We focus on developing innovative vaccine technologies 🦠 🧬 🥼 Managed by Hoffmann Lab members
San Francisco, CA
Joined October 2022
- Tweets59
- Following210
- Followers227
- Likes97
Way to go, @bjorkmanlab! Well deserved!
‘For pioneering innovative strategies to overcome viral defenses through novel antibody-focused approaches.’: Pamela Bjorkman, Wolf Prize Laureate in Medicine 2025, has revolutionized our approach to viral defense with her novel, antibody-focused strategies.
Join us in celebrating her groundbreaking impact!
@Caltech
#Medicine #wolfprize2025 #wolfprizelaureate #wp2025medicine #wp2025
Hoffmann Lab retweeted
Gladstone’s Magnus Hoffmann (@mhofflab) seeks to advance a new generation of more effective vaccines, improved drug delivery methods, and a greater overall understanding of vaccine-induced immune responses.
bit.ly/4hDlmzm
The Hoffmann lab is thrilled to announce that we are now a part of the @GladstoneInst! We are so grateful for the opportunity to continue our research among such talented and influential scientists.
Magnus Hoffmann opened his lab at Gladstone Institutes earlier this year with a mission to create a vaccine platform that provides long-lasting immune protection against a wide range of pathogens.
Read more: bit.ly/4hDlmzm
Check out Dr. Hoffmann's interview with @VaccineInsights! Learn about our lab's innovative work with hybrid mRNA vaccines is revolutionizing vaccine development. 🦠
insights.bio/vaccine-insight…
Thanks for inviting the Hoffmann lab to the party, @bjorkmanlab!
Hoffmann Lab retweeted
Caltech researchers, led by Professor Pamela Björkman, have imaged an elusive HIV protein structure at the atomic scale, offering unprecedented insights into the HIV infection process. #WorldAIDSDay2023
caltech.edu/about/news/imagi…
Hoffmann Lab retweeted
🔬 Exciting findings in our latest publication out in @nature! This work delves into the dynamic world of HIV-1 envelope structures, revealing distinct conformational changes during host receptor (CD4) engagement. 🧬💡
Hoffmann Lab retweeted
The antibodies produced by the new vaccine were effective against the original strain of SARS-CoV-2, the delta variant, and omicron variants.
caltech.edu/about/news/new-v…
Learn more on how the EABR technology is revolutionizing vaccination efforts: caltech.edu/about/news/new-v…
Kudos to our team @Caltech and collaborators! @bjorkmanlab @yangzcit
Check out the @CellCellPress paper for more details. 📚 #Vaccines #Innovation
Excited to introduce our new postdoc @SamehAli8893!
Beyond thrilled to share that I joined @Caltech as a Postdoctoral Scholar Research Associate in the @mhofflab and @bjorkmanlab. Looking forward to the exciting times ahead!
Sending thanks and deep appreciation to our friends Marta and Mark in the @bjorkmanlab! We are blessed to have such dedicated, incredible individuals to work alongside 😊
Today, @Caltech honored our very own Marta and Mark for their dedicated service to the Institute and our Lab. You guys are amazing and we are so lucky to have you! Thank you for everything, you guys make Caltech a much better place 🧡
Hoffmann Lab retweeted
A novel vaccine strategy that combines the flexibility and speed of mRNA and superior nanoparticle immunogenicity (VLPs-virus like particles)
cell.com/cell/fulltext/S0092… @seth_zost @RHCarnahan
cell.com/cell/fulltext/S0092… @bjorkmanlab @Caltech
We're thrilled to share that our work describing the innovative EABR technology has been published in @CellCellPress! This has the potential to revolutionize vaccine development & help us fight against #COVID19 & other diseases!
A great collaboration with the @bjorkmanlab!
Now online! ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines dlvr.it/SmrjQy
For more details on this work, check out our 🧵:
xitter.cf/mhofflab/status/161064…
Check out our preprint describing the EABR technology, which enables combining features of mRNA- and protein nanoparticle-based vaccines through genetic encoding of self-assembling enveloped virus-like particles (eVLPs)!
doi.org/10.1101/2022.12.26.5…
Collab with @bjorkmanlab! 🧵(1/n)
Hoffmann Lab retweeted
Researchers are advancing #vaccine technologies to prevent the next pandemic and #cancer.
Learn how @mhofflab @Caltech, @AnnaBlakney @UBC, @AliasgerSalem @uiowa, and Jinjun Shi @harvardmed develop novel vaccine platforms.
📆 Mon, Feb 27 @ 1:30PM EST
ow.ly/YJpI50MCwQJ
Hoffmann Lab retweeted
Don't miss our latest webinar happening Monday!
Join @mhofflab @Caltech, @AnnaBlakney @UBC, @AliasgerSalem @uiowa, and Jinjun Shi @harvardmed as they discuss rapidly evolving vaccine technology.
📆 Monday, February 27 @ 1:30 PM EST
Claim your spot now:
ow.ly/M75y50N1sBF
Hoffmann Lab retweeted
Dr Kim Dam is representing the Bjorkman Lab and @mhofflab at the CAVD Norman L. Letvin Early Career Investigator Conference in South Africa! We couldn’t ask for a better scientist to showcase our work to the world ☺️
Hoffmann Lab retweeted
As #mRNA research and #nanotechnology advance, what will future #vaccines be like?
Hear @mhofflab @Caltech, @AnnaBlakney @UBC, @AliasgerSalem @uiowa, and Jinjun Shi @harvardmed discuss the latest vaccine developments.
📆 February 27 @ 1:30PM EST
ow.ly/59ho50MShj0
Hoffmann Lab retweeted
Learn more about this study and novel #vaccine technologies at our webinar.
@mhofflab @Caltech, @AnnaBlakney @UBC, @AliasgerSalem @uiowa, and Jinjun Shi @harvardmed will discuss recent breakthroughs in vaccine development.
📅Feb 27 @ 1:30PM ET
Register:
ow.ly/9GSe50MCx7J
Check out our preprint describing the EABR technology, which enables combining features of mRNA- and protein nanoparticle-based vaccines through genetic encoding of self-assembling enveloped virus-like particles (eVLPs)!
doi.org/10.1101/2022.12.26.5…
Collab with @bjorkmanlab! 🧵(1/n)